<DOC>
	<DOCNO>NCT00142311</DOCNO>
	<brief_summary>Parkinson ’ disease one frequent neurodegenerative disease , mechanism remain unknown . Since implication susceptibility factor highly suspect , recently show one monogenic form due alteration Parkin gene responsible important proportion early onset familial isolated case . Nevertheless , determine yet relationship idiopathic Parkinson ’ disease secondary Parkinson ’ disease Parkin gene mutation clinical , neuropsychological , metabolic physiopathological level . For establish phenotype-genotype correlation , propose compare phenotype patient carry Parkin mutation ( parkin « + » , n=25 ) early onset parkinsonians without Parkin mutation ( Parkin ” - ” , n = 25 ) , aspect ( neuropsychological , behavioural psychiatric evaluation ) healthy brother sister Parkin case “ + ” ( n = 25 ) . The evaluation carry clinical aspect ( quantification parkinsonian syndrome reactivity levodopa , neuropsychological , behavioural psychiatric evaluation ) , molecular ( types abnormality Parkin gene ) metabolic ( PET – tomography positron emission ) disease . Parkinson ’ disease cause Parkin gene mutation associate important homogeneous loss dopaminergic neuron substantia nigra par compacta , different observe idiopathic Parkinson ’ disease . The corresponding dopaminergic deficit associate excellent reactivity levodopa , cognitive deficit behavioural and/or psychiatric attitude , relation massive alteration dopaminergic efferences . This multidisciplinary approach Parkin case perform center clinical investigation Grenoble Paris , help French Parkinson ’ Disease Study Group , two center TEP ( Lyon Orsay ) . This project allow good definition diagnostic criterion Parkin « + » case , help molecular diagnosis early onset case , study precisely clinical , psychiatric metabolic consequence massive homogeneous dopaminergic denervation , seem different idiopathic Parkinson ’ disease .</brief_summary>
	<brief_title>Functional Characterization Parkin + Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Age onset 45 Presence least two three cardinal sign : bradykinesia , rigidity dental wheel , postural tremor Frank response LDopa ( &gt; 30 % ) Absence personal history meningitisencephalopathy , neuroleptic treatment , absence pyramidal , cerebellar oculomotor sign , absence dysautonomia dementia occur less 2 year onset disease Exclusion Wilson 's disease usual biological test Normal cerebral MRI Incapacity patient understand participate protocol Patients present contraindication realization cerebral MRI ( pacemaker , cardiac valve , ustensile neurosurgery vascular surgery , intraocular tissue ) could include group patient PET . Women age procreate could participate study PET , use effective contraception ( oestroprogestives coil ) . Furthermore , date PET examination begin menstrual cycle . At first doubt , dosage bHCG perform .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Parkin mutation</keyword>
	<keyword>Metabolic exploration</keyword>
	<keyword>Clinics</keyword>
	<keyword>Genetics</keyword>
</DOC>